IDB gives vaccine updates

ID Biomedical (TSX:IDB; IDBE) said that, based on a pre-IND meeting with FDA, it does not expect to begin pediatric trials of StreptAvax vaccine prior to 2007. In January, IDB said it expected to begin a pediatric Phase II trial of the group A streptococcus vaccine this year. The company said the agency asked for a "significant amount" of additional information and follow-up from a recently completed adult trial before pediatric trials may begin. ...